NCT00137020 Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder Status COMPLETED Phase PHASE4
NCT00136994 IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study) Status COMPLETED Phase PHASE3
NCT00132314 Long-Acting Injectable Risperidone in the Treatment of Schizophrenia Status COMPLETED Phase PHASE3
NCT00130923 Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder Status COMPLETED Phase PHASE4
NCT00124683 Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1 Status COMPLETED Phase PHASE2
NCT00119756 A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00113594 Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder Status COMPLETED Phase PHASE3
NCT00111189 A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia. Status COMPLETED Phase PHASE3
NCT00108303 Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes Status COMPLETED Phase N/A
NCT00105326 Trial Evaluating Paliperidone Extended-Release (ER) Tablets Versus Placebo on Sleep in Schizophrenia Patients Status COMPLETED Phase PHASE2
NCT00103727 Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia Status COMPLETED Phase PHASE2
NCT00103571 Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT00102479 Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents Status COMPLETED Phase PHASE2